Willem Flameng
Corporate Officer/Principal chez Katholieke Universiteit Leuven
Postes actifs de Willem Flameng
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Katholieke Universiteit Leuven | Corporate Officer/Principal | - | - |
Historique de carrière de Willem Flameng
Anciens postes connus de Willem Flameng
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Anethon NV
 Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | Directeur/Membre du Conseil | 01/07/2011 | 07/08/2013 |
| Fondateur | 01/07/2011 | 07/08/2013 | |
| Corporate Officer/Principal | 01/07/2011 | 07/08/2013 |
Statistiques
Internationale
| Belgique | 3 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Founder | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Anethon NV
Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | Health Technology |
- Bourse
- Insiders
- Willem Flameng
- Expérience
